Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

arch wood protection (aust) pty limited - copper (cu) present as copper naphthenate; liquid hydrocarbon - emulsion - copper (cu) present as copper naphthenate mineral-copper active 20.0 g/l; liquid hydrocarbon solvent other 720.0 g/l - mixed function pesticide - timber | wood - borer | fungal decay | decay fungi

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

arch wood protection (aust) pty limited - copper (cu) present as copper naphthenate; liquid hydrocarbon - emulsion - copper (cu) present as copper naphthenate mineral-copper active 15.0 g/kg; liquid hydrocarbon solvent other 620.0 g/kg - mixed function pesticide - timber | wood - borer | fungal decay | decay fungi

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - hydroxyethyl starch 130/0.4 6 g in 100 ml - 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection is indicated for the treatment and prophylaxis of hypovolemia in adults and children. it is not a substitute for red blood cells or coagulation factors in plasma. - do not use hydroxyethyl starch (hes) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy (rrt).  - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with severe liver disease. - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with known hypersensitivity to hydroxyethyl starch [see general warnings and precautions (5.1) ] - do not use hes products in clinical conditions with volume overload.  - do not use hes products in patients with pre-existing coagulation or bleeding disorders.  - do not use h

United States - English - NLM (National Library of Medicine)

h and p industries, inc. dba triad group - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 0.51 g - protectant - provides temporary relief of the itching, burning and discomfort associated with hemorrhoids and other anorectal disorders - provides a coating to protect irritated tissue

United States - English - NLM (National Library of Medicine)

hospira, inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58) - hydroxyethyl starch 130/0.4 6 g in 100 ml - voluven ® (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) is indicated for the treatment and prophylaxis of hypovolemia in adults and children. it is not a substitute for red blood cells or coagulation factors in plasma. - do not use hydroxyethyl starch (hes) products, including voluven ® , in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy (rrt). - do not use hes products, including voluven ® , in patients with severe liver disease. - do not use hes products, including voluven ® , in patients with known hypersensitivity to hydroxyethyl starch [see general warnings and precautions (5.1) ] - do not use hes products in clinical conditions with volume overload. - do not use hes products in patients with pre-existing coagulation or bleeding disorders. - do not use hes products in patients with renal failure with oliguria or anuria not related

United States - English - NLM (National Library of Medicine)

zoetis inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58) - hydroxyethyl starch 130/0.4 6000 mg in 100 ml - vetstarch™ (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) is indicated for the treatment and prophylaxis of hypovolemia. it is not a substitute for red blood cells or coagulation factors in plasma. the use of vetstarch™ is contraindicated in the following conditions: • known hypersensitivity to hydroxyethyl starch [see general warnings and precautions (5.1)]  • fluid overload (hyperhydration) and especially in cases of pulmonary edema and congestive heart failure • renal failure with oliguria or anuria not related to hypovolemia • patients receiving dialysis treatment • severe hypernatremia or severe hyperchloremia • intracranial bleeding the type of hydroxyethyl starch present in vetstarch had no teratogenic properties in rats or rabbits. at 5 g/kg of body weight per day, administered as a bolus injection, fetal retardations and embryolethal effects were observed in rats and rabbits, respectively. in rats, a bolus injection of this dose during pregnancy and lactation reduced body

United States - English - NLM (National Library of Medicine)

e-house korea holdings international - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 3.16 g in 4 g

United States - English - NLM (National Library of Medicine)

e-house korea holdings international - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 3.16 g in 4 g

United States - English - NLM (National Library of Medicine)

bayer healthcare llc - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 837 mg in 1 g - skin protectant temporarily protects and helps relieve minor skin irritation

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.